The present invention relates to a novel antibody and antibody fragment specifically binding to the B cell maturation antigen (BCMA), and relates in particular to a fully human single chain variable fragment (scFv). The present invention also relates to a nucleic acid encoding the antibody, a vector, a host cell expressing the nucleic acid, a composition including the antibody, and a use of the composition in treatment and diagnosis.